InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.00%
)
US TECH 100
16,888.80
(
-1.01%
)
Dow Jones
38,460.92
(
0.00%
)
Brent Oil
87.29
(
0.08%
)
Bitcoin
63,774.95
(
-0.79%
)
Post# of 43
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jasonak

Send PM Follow Ignore
Followers 16
Posts 332
Boards Moderated 0
Alias Born 12/30/2004

jasonak

Member Level

Re: abc2438 post# 25

Wednesday, 03/15/2017 2:53:55 AM

Wednesday, March 15, 2017 2:53:55 AM

Post# of 43
"The increase reflects the monetization of the U.S. Crinone® royalty stream as previously described, which would otherwise have expired in July 2020. Juniper will not receive royalty payments from Allergan in future periods."

Without this one time gain of the big $11m payment from Allergan in the 4Q JNP would of lost $5m plus for the year.

It appears they discounted an asset for instant cash...so it all depends on what they do with the cash.

Am I missing something?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up